Nuvation Bio Inc. (NUVB) Social Stream
NUVATION BIO INC (NUVB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NUVATION BIO INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-01 | 3 | $23 | $18 | $20.5 | $1.6 | 1181.25% |
| 2022-05-04 | 4 | $23 | $14 | $18.333 | $1.6 | 1045.81% |
| 2022-05-09 | 4 | $23 | $14 | $17.333 | $1.6 | 983.31% |
| 2022-05-12 | 4 | $17 | $14 | $15.333 | $1.6 | 858.31% |
| 2022-06-28 | 4 | $17 | $13 | $14.666 | $1.6 | 816.62% |
| 2022-08-05 | 6 | $14 | $2.5 | $8.625 | $1.6 | 439.06% |
| 2022-11-07 | 6 | $5 | $2.5 | $4.25 | $1.6 | 165.62% |
| 2023-01-06 | 5 | $5 | $2 | $3.5 | $1.6 | 118.75% |
| 2023-05-05 | 6 | $5 | $1.8 | $3.45 | $1.6 | 115.62% |
| 2023-05-10 | 7 | $5 | $1.8 | $3.76 | $1.6 | 135% |
| 2023-11-02 | 6 | $5 | $1.8 | $4.075 | $1.6 | 154.69% |
| 2023-11-22 | 6 | $5 | $1.4 | $3.975 | $1.6 | 148.44% |
The Trend in the Analyst Price Target
NUVB's average price target has moved down $14.69 over the prior 21 months.
NUVB reports an average of 145.96% for its upside potential over the past 36 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-24 | 6 | 5 | 1.8 | 3.450 | 1.64 | 110.37% |
| 2023-05-10 | 7 | 5 | 1.8 | 3.760 | 1.61 | 133.54% |
| 2023-08-21 | 6 | 5 | 1.8 | 4.075 | 1.66 | 145.48% |
| 2023-11-03 | 6 | 5 | 1.4 | 3.975 | 1.35 | 194.44% |
| 2023-11-22 | 6 | 5 | 1.4 | 3.975 | 1.26 | 215.48% |
NUVB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.83 | 3 | 1 | 2 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 52 weeks, NUVB's average broker recommendation rating worsened by 0.16.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, NUVATION BIO INC's upside potential (average analyst target price relative to current price) is higher than 1916.33% of them.
- NUVB has a greater average analyst price target than 274.91% of all US stocks.
- In the context of stocks in the mid market cap category, NUVATION BIO INC's number of analysts covering the stock is greater than 532.65% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, NUVATION BIO INC's variance in analysts' estimates is lower than -1198.41% of them.
In the Pharmaceutical Products industry, NKTX, ALXO, and HRMY are the three stocks most similar to NUVATION BIO INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for NUVB? Use POWR Ratings for clearer insight into price direction.